How many insider trades does FilingIQ track for NCEL?

FilingIQ tracks 4 Form 4 insider transactions for NCEL (NewcelX Ltd.), covering filings from Apr 27, 2026 onwards. 4 of those were filed in the last 90 days.

Are NCEL insiders net buyers or net sellers?

Across the full Form 4 history for NCEL, 4 transactions (100%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NCEL insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NCEL in?

NewcelX Ltd. (NCEL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $17.75M.

NCEL insider trading

NasdaqCM Healthcare

NewcelX Ltd. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

100% / 0%

Market cap

$17.75M

About NewcelX Ltd.

NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.

Company website: newcelx.com

NCEL insider activity at a glance

FilingIQ has scored 4 insider transactions for NCEL since Apr 27, 2026. The most recent filing in our index is dated Apr 27, 2026.

Across the full history, 4 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NCEL insider trades is 55.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NCEL trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for NCEL?: FilingIQ tracks 4 Form 4 insider transactions for NCEL (NewcelX Ltd.), covering filings from Apr 27, 2026 onwards. 4 of those were filed in the last 90 days.
Are NCEL insiders net buyers or net sellers?: Across the full Form 4 history for NCEL, 4 transactions (100%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NCEL insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NCEL in?: NewcelX Ltd. (NCEL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $17.75M.

Methodology & sources

Every NCEL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.